Recombinant Mouse STNF RII/TNFRSF1B #abs01004

abs01004-5ug

1-2 Weeks

138

abs01004-20ug

1-2 Weeks

344

abs01004-1mg

1-2 Weeks

3891

Species

Murine

Source

Escherichia coli.

Format

The solution in PBS, pH 7.4 was filtered through a 0.2 μm filter and then lyophilized to create a dry powder. This process ensures that the resulting substance is pure and stable for future use.

Properties

aa_sequence

GKTWNCQVQV PECQYEPGKP KQRYDYSEYA GQPPCGKCCA QNKTHCFHKV EASCDCATVQ FRNQWVQTYM CSSCTSSSCL CAQRIEVDQT CECARNQNKR HGSYKLACAR LMRCQCRSGS AVGFGPGCCK LVNGNPARSS FATGPGACAP RVDCATSATD AISLTPSEPQ EVSQPYLTRL EQDPLQPSQT TPSTIQPSGP ETPILISTSL GGIEIPTSGQ KTKS.

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method determined that the content of rMusTNF RII/TNFRSF1B is below 0.1 EU/μg. Let me rearrange the sentence to generate highly similar content based on the original text: According to the LAL method, the determined level of rMusTNF RII/TNFRSF1B falls below 0.1 EU/μg.

Activity

Compared to the standard, it has full biological activity. The effective dose (ED) is equivalent to that of the original. Please create a similarly aligned content by reorganizing the original text, making sure the resulting content remains true to the original information.₅₀The specific activity of the tested protein, which was determined by its ability to inhibit TNF-α mediated cytotoxicity in L-929 cells, was found to be less than 2 μg/ml. This translates to a specific activity level of > 500 IU/mg when tested in the presence of 0.1 ng/mL of rMuTNF-α. These results demonstrate the effectiveness of the protein in inhibiting the production of TNF-α and may be promising for potential therapeutic applications.

Reconstitution

Before opening, it is advised that this vial be briefly centrifuged in order to allow its contents to settle at the bottom. To create a concentration of 0.1-1.0 mg/mL, reconstitute the product in either sterile distilled water or an aqueous buffer containing 0.1 % BSA. After creating a stock solution, divide it into working aliquots and store it at ≤ -20 °C. Any subsequent dilutions should be made using appropriate buffered solutions.

Stability & Storage

To ensure the stability of this lyophilized preparation, it is recommended to store it at 2-8 °C, but for long-term storage, it should be kept at -20 °C and preferably desiccated. After reconstitution, the preparation remains stable for up to seven days at 2-8 °C. For the best stability, it is advised to divide the reconstituted preparation into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid exposing the preparation to multiple freeze/thaw cycles which can compromise its stability.

Target

Accession

P25119

Gene IDs

21938